Human ACVR1B recombinant protein with polyhistidine tag at the C-terminus expressed in Escherichia coli.
Sequence:
MGLECDGRTNLCCRQQFFIDFRLIGWNDWIIAPTGYYGNYCEGSCPAYLAGVPGSASSFHTAVVNQYRMRGLNPGTVNSCCIPTKLSTMSMLYFDDEYNIVKRDVPNMIVEECGCA with polyhistidine tag at the C-terminus.
Host:
Escherichia coli
Form:
Lyophilized
Preparation Method:
Escherichia coli expression system
Purification:
Ni-NTA chromatography
Purity:
> 98% as determined by SDS-PAGE.
Endotoxin Level:
< 0.1 EU/ ug of protein by the LAL method.
Activity:
ED50 < 0.7 ng/mL, measure by its ability to induce induce hemoglobin expression in K562 cells. The specific activity of recombinant human Activin B is > 1.5 x 106 IU/mg.
Quality Control Testing:
SDS-PAGE Stained with Coomassie Blue.
SDS-PAGE analysis of ACVR1B (Human) Recombinant Protein.
Recommend Usage:
Biological Activity SDS-PAGE The optimal working dilution should be determined by the end user.
Storage Buffer:
Lyophilized from a solution containing 1X PBS, pH 8.0. Reconstitute the lyophilized powder in ddH2O to 100 ug/mL.
Storage Instruction:
Lyophilized protein should be stored at -20°C. Protein aliquots should be stored at-20°C to -80°C.
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with a cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type IB receptor, composed of 11 exons. Alternative splicing and alternative polyadenylation result in 3 fully described transcript variants. The mRNA expression of variants 1, 2, and 3 is confirmed, and a potential fourth variant contains an alternative exon 8 and lacks exons 9 through 11, but its mRNA expression has not been confirmed. [provided by RefSeq
Other Designations:
activin A receptor, type II-like kinase 4,activin A type IB receptor,activin receptor-like kinase 4,serine(threonine) protein kinase receptor R2